Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402Akira Inoue, Toshihiro Nukiwa, Koichi Yamazaki et al.|Journal of Clinical Oncology|2008Cited by 235
Cyclooxygenase-2 inhibitors for non-small-cell lung cancer: A phase II trial and literature reviewHiroshi Yokouchi, Masaharu Nishimura|Molecular and Clinical Oncology|2014Cited by 17